Hence, the aim of this research was to explore galectin-3 and FGF-23 in relation to T2D, as well as to examine the potential association of these biomarkers with atherosclerotic cardiovascular disease (ASCVD) risk score in Montenegrin adults.<h4>Methods</h4>A total of 35 T2D patients and 36 controls were consecutively enrolled. This evidence concerns the gene FGF23 and type 2 diabetes mellitus.